Item request has been placed!
×
Item request cannot be made.
×
Processing Request
61P First-line camrelizumab (Camre) plus carboplatin (Carbo) and pemetrexed (Pem) for advanced non-squamous NSCLC: 5-yr outcomes of CameL phase III study
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Zhou, C.; Chen, G.; Huang, Y.; Zhou, J.; Lin, L.; Feng, J.; Wang, Z-H.; Shu, Y.; Shi, J.; Hu, Y.; Wang, Q-M.; Cheng, Y.; Wu, F.; Chen, J.; Lin, X.; Wang, Y.; Huang, J.; Cui, J.; Wang, Z.; Ma, X.
- المصدر:
ESMO Open ; volume 9, page 102640 ; ISSN 2059-7029
- نوع التسجيلة:
article in journal/newspaper
- اللغة:
English
- معلومة اضافية
- بيانات النشر:
Elsevier BV
- الموضوع:
2024
- Collection:
ScienceDirect (Elsevier - Open Access Articles via Crossref)
- الرقم المعرف:
10.1016/j.esmoop.2024.102640
- Rights:
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
- الرقم المعرف:
edsbas.3BC69BC4
No Comments.